Sympathetic and hemodynamic effects of moderate and deep sedation with propofol in humans.
BACKGROUND
The objective of this study was to determine the mechanisms involved in the hypotension associated with sedative doses of propofol in humans.


METHODS
Ten healthy volunteers (aged 21-37 yr) participated on two occasions and in random order received placebo or propofol infusions. Standard monitoring and radial artery blood pressure were combined with measurement of forearm blood flow (plethysmography) and derivation of forearm vascular resistance, recording of peroneal nerve sympathetic activity, and blood sampling for norepinephrine concentrations. A computer-controlled infusion pump delivered placebo or two concentrations of propofol, adjusted to achieve moderate and deep sedation based on the Observer Assessment of Alertness/Sedation score (responsiveness component) of 4 and 3. Level of sedation was quantitated using bispectral analysis of the electroencephalogram. Baroreflexes were assessed with a hypotensive challenge via administration of sodium nitroprusside.


RESULTS
Baseline neurocirculatory and respiratory parameters did not differ between sessions. Progressive infusions to achieve moderate and deep sedation resulted in average Bispectral Index values of 70 and 54, respectively. Propofol significantly reduced sympathetic nerve activity at both levels of sedation and decreased norepinephrine and forearm vascular resistance at deep sedation. These effects resulted in significant decreases in mean blood pressure of 9% and 18% at moderate and deep sedation, respectively. Propofol also reduced reflex increases in sympathetic nerve activity.


CONCLUSIONS
These data from healthy subjects indicate that sedation doses of propofol, which did not compromise respiratory function, had substantial inhibitory effects on sympathetic nerve activity and reflex responses to hypotension resulting in vasodilation and significant decreases in mean blood pressure.
Ebert
Thomas J
TJ
Department of Anesthesiology, The Medical College of Wisconsin, and the Veterans Affairs Medical Center, Milwaukee, Wisconsin 53295, USA. tjebert@mcw.edu
D000320:Adrenergic Fibers / Q000187:drug effects* / Q000502:physiology; D000328:Adult; D017704:Baroreflex / Q000187:drug effects / Q000502:physiology; D001794:Blood Pressure / Q000187:drug effects* / Q000502:physiology; D005260:Female; D006339:Heart Rate / Q000187:drug effects* / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage*; D016014:Linear Models; D008297:Male; D015742:Propofol / Q000008:administration & dosage*; D013565:Sympatholytics / Q000008:administration & dosage
D006993:Hypnotics and Sedatives; D013565:Sympatholytics; D015742:Propofol